OA
BSX.PRA

Oxbow Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Oxbow Advisors’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$5.09M Sell
2022
Q1 		$11.9M Sell
2021
Q4 		$12M Buy